PubRank

Joseph A Odin

Author PubWeight™ 27.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology 2006 2.08
2 Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet 2010 1.62
3 Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res 2004 1.57
4 Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver Int 2013 1.43
5 Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet 2012 1.32
6 Cholestatic liver injury associated with whey protein and creatine supplements. Semin Liver Dis 2008 1.08
7 Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology 2014 1.05
8 T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 2007 1.03
9 Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J Immunotoxicol 2009 1.01
10 Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. Hepatology 2004 0.97
11 Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology 2004 0.95
12 Toll-like receptors and liver disease. Liver Int 2013 0.92
13 Pathogenic role of environmental toxins in immune-mediated liver diseases. J Immunotoxicol 2008 0.91
14 Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J Autoimmun 2007 0.90
15 Evaluation of fatigue in U.S. patients with primary biliary cirrhosis. Am J Gastroenterol 2005 0.89
16 The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis. Biochem J 2002 0.85
17 Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis 2005 0.84
18 Recent advances in the epidemiology of primary biliary cirrhosis. Clin Liver Dis 2008 0.84
19 Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia. Inflamm Bowel Dis 2013 0.84
20 Autoimmune cholangitis in the SJL/J mouse is antigen non-specific. Dev Immunol 2002 0.81
21 Apoptosis and the liver: relation to autoimmunity and related conditions. Autoimmun Rev 2003 0.80
22 Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis. Dig Dis Sci 2008 0.80
23 Primary biliary cirrhosis: a Mount Sinai perspective. Mt Sinai J Med 2003 0.78
24 Vaccination as a triggering event for autoimmune hepatitis. Semin Liver Dis 2009 0.78
25 Update on the epidemiology of primary biliary cirrhosis. Expert Rev Gastroenterol Hepatol 2011 0.77
26 Maternal allergy acts synergistically with cigarette smoke exposure during pregnancy to induce hepatic fibrosis in adult male offspring. J Immunotoxicol 2011 0.77
27 Catalase and estradiol inhibit mitochondrial protein S-glutathionylation. Mol Cell Biochem 2012 0.76
28 Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study. Hepatol Res 2009 0.75
29 Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregates. Dig Dis Sci 2013 0.75